191 related articles for article (PubMed ID: 24664418)
1. Antiretroviral protease inhibitors accelerate glutathione export from viable cultured rat neurons.
Brandmann M; Hohnholt MC; Petters C; Dringen R
Neurochem Res; 2014 May; 39(5):883-92. PubMed ID: 24664418
[TBL] [Abstract][Full Text] [Related]
2. The antiretroviral protease inhibitor ritonavir accelerates glutathione export from cultured primary astrocytes.
Arend C; Brandmann M; Dringen R
Neurochem Res; 2013 Apr; 38(4):732-41. PubMed ID: 23341120
[TBL] [Abstract][Full Text] [Related]
3. The antiretroviral protease inhibitors indinavir and nelfinavir stimulate Mrp1-mediated GSH export from cultured brain astrocytes.
Brandmann M; Tulpule K; Schmidt MM; Dringen R
J Neurochem; 2012 Jan; 120(1):78-92. PubMed ID: 22017299
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of HIV-1 protease inhibitors on insulin secretion and insulin signaling in INS-1 beta cells.
Schütt M; Zhou J; Meier M; Klein HH
J Endocrinol; 2004 Dec; 183(3):445-54. PubMed ID: 15590971
[TBL] [Abstract][Full Text] [Related]
5. Direct interference of HIV protease inhibitors with pancreatic beta-cell function.
Düfer M; Neye Y; Krippeit-Drews P; Drews G
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jun; 369(6):583-90. PubMed ID: 15197535
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of HIV protease inhibitors on adipogenesis: intracellular ritonavir is not sufficient to inhibit differentiation.
Vernochet C; Azoulay S; Duval D; Guedj R; Ailhaud G; Dani C
AIDS; 2003 Oct; 17(15):2177-80. PubMed ID: 14523274
[TBL] [Abstract][Full Text] [Related]
7. Co-treatment With HIV Protease Inhibitor Nelfinavir Greatly Increases Late-phase Apoptosis of Drug-resistant KBV20C Cancer Cells Independently of P-Glycoprotein Inhibition.
Kim JY; Park YJ; Lee BM; Yoon S
Anticancer Res; 2019 Jul; 39(7):3757-3765. PubMed ID: 31262902
[TBL] [Abstract][Full Text] [Related]
8. Ritonavir, nelfinavir, saquinavir and lopinavir induce proteotoxic stress in acute myeloid leukemia cells and sensitize them for proteasome inhibitor treatment at low micromolar drug concentrations.
Kraus M; Müller-Ide H; Rückrich T; Bader J; Overkleeft H; Driessen C
Leuk Res; 2014 Mar; 38(3):383-92. PubMed ID: 24418752
[TBL] [Abstract][Full Text] [Related]
9. The effect of HIV protease inhibitors on amyloid-β peptide degradation and synthesis in human cells and Alzheimer's disease animal model.
Lan X; Kiyota T; Hanamsagar R; Huang Y; Andrews S; Peng H; Zheng JC; Swindells S; Carlson GA; Ikezu T
J Neuroimmune Pharmacol; 2012 Jun; 7(2):412-23. PubMed ID: 21826404
[TBL] [Abstract][Full Text] [Related]
10. Short time exposure to hydrogen peroxide induces sustained glutathione export from cultured neurons.
Hohnholt MC; Dringen R
Free Radic Biol Med; 2014 May; 70():33-44. PubMed ID: 24524999
[TBL] [Abstract][Full Text] [Related]
11. Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlations.
Lafeuillade A; Solas C; Halfon P; Chadapaud S; Hittinger G; Lacarelle B
HIV Clin Trials; 2002; 3(1):27-35. PubMed ID: 11819183
[TBL] [Abstract][Full Text] [Related]
12. Arsenate stimulates glutathione export from viable cultured rat cerebellar granule neurons.
Hohnholt MC; Blumrich EM; Koehler Y; Dringen R
Neurochem Res; 2015 Mar; 40(3):561-71. PubMed ID: 25503647
[TBL] [Abstract][Full Text] [Related]
13. P-Glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: potential for accelerated viral drug resistance?
Jones K; Bray PG; Khoo SH; Davey RA; Meaden ER; Ward SA; Back DJ
AIDS; 2001 Jul; 15(11):1353-8. PubMed ID: 11504956
[TBL] [Abstract][Full Text] [Related]
14. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
Profit L; Eagling VA; Back DJ
AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562
[TBL] [Abstract][Full Text] [Related]
15. Mutational patterns and correlated amino acid substitutions in the HIV-1 protease after virological failure to nelfinavir- and lopinavir/ritonavir-based treatments.
Garriga C; Pérez-Elías MJ; Delgado R; Ruiz L; Nájera R; Pumarola T; Alonso-Socas Mdel M; García-Bujalance S; Menéndez-Arias L;
J Med Virol; 2007 Nov; 79(11):1617-28. PubMed ID: 17854027
[TBL] [Abstract][Full Text] [Related]
16. Interactions of HIV protease inhibitors with a human organic cation transporter in a mammalian expression system.
Zhang L; Gorset W; Washington CB; Blaschke TF; Kroetz DL; Giacomini KM
Drug Metab Dispos; 2000 Mar; 28(3):329-34. PubMed ID: 10681378
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus protease inhibitors interact with ATP binding cassette transporter 4/multidrug resistance protein 4: a basis for unanticipated enhanced cytotoxicity.
Fukuda Y; Takenaka K; Sparreboom A; Cheepala SB; Wu CP; Ekins S; Ambudkar SV; Schuetz JD
Mol Pharmacol; 2013 Sep; 84(3):361-71. PubMed ID: 23775562
[TBL] [Abstract][Full Text] [Related]
18. Exposure to HIV-protease inhibitors selects for increased expression of P-glycoprotein (ABCB1) in Kaposi's sarcoma cells.
Lucia MB; Anu R; Handley M; Gillet JP; Wu CP; De Donatis GM; Cauda R; Gottesman MM
Br J Cancer; 2011 Aug; 105(4):513-22. PubMed ID: 21829205
[TBL] [Abstract][Full Text] [Related]
19. Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir.
Sulkowski MS; Mehta SH; Chaisson RE; Thomas DL; Moore RD
AIDS; 2004 Nov; 18(17):2277-84. PubMed ID: 15577540
[TBL] [Abstract][Full Text] [Related]
20. HIV protease inhibitors: suppression of insulin secretion by inhibition of voltage-dependent K+ currents and anion currents.
Neye Y; Düfer M; Drews G; Krippeit-Drews P
J Pharmacol Exp Ther; 2006 Jan; 316(1):106-12. PubMed ID: 16162820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
